INMED PHARMACEUTICALS INC. Increase (Decrease) in Other Noncurrent Assets
INMED PHARMACEUTICALS INC. (INM) reported Increase (Decrease) in Other Noncurrent Assets of $32.32 thousand for the 12-month period ending 2026-06-30, per its S-4/A filed 2026-09-09.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-09-09
- INMED PHARMACEUTICALS INC. increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was $27.96K.
- INMED PHARMACEUTICALS INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-06-30 was $0.00.
- INMED PHARMACEUTICALS INC. increase (decrease) in other noncurrent assets for the quarter ending 2024-06-30 was $0.00.
- INMED PHARMACEUTICALS INC. increase (decrease) in other noncurrent assets for the quarter ending 2024-03-31 was $0.00.
- INMED PHARMACEUTICALS INC. increase (decrease) in other noncurrent assets for fiscal 2023 was -$5.51K, a 108.96% decline from fiscal 2022.
- INMED PHARMACEUTICALS INC. increase (decrease) in other noncurrent assets for fiscal 2022 was $61.43K, a 333.81% increase from fiscal 2021.
- INMED PHARMACEUTICALS INC. increase (decrease) in other noncurrent assets for fiscal 2021 was $14.16K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $27.96K derived: S-4/A 12 month − S-4 9 month · filed 2026-09-09 | $32.32K S-4/A · filed 2026-09-09 | ||
| 2026-03-31 | $4.37K S-4 · filed 2026-07-02 | |||
| 2025-06-30 | $0.00 derived: S-4/A 12 month − S-4 9 month · filed 2026-09-09 | $0.00 S-4/A · filed 2026-09-09 | ||
| 2025-03-31 | $0.00 S-4 · filed 2026-07-02 | |||
| 2024-06-30 | $0.00 derived: S-4 12 month − 10-Q 9 month · filed 2026-07-02 | $0.00 derived: sum of 2 quarters · filed 2026-07-02 | -$1.79K derived: sum of 3 quarters · filed 2026-07-02 | -$4.91K S-4 · filed 2026-07-02 |
| 2024-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-12 | -$1.79K derived: sum of 2 quarters · filed 2025-05-12 | -$4.91K 10-Q · filed 2025-05-12 | -$4.91K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | -$1.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-12 | -$4.91K 10-Q · filed 2025-02-12 | -$4.91K derived: sum of 3 quarters · filed 2025-02-12 | -$4.91K derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-09-30 | -$3.12K 10-Q · filed 2024-11-14 | -$3.12K derived: sum of 2 quarters · filed 2024-11-14 | -$3.12K derived: sum of 3 quarters · filed 2024-11-14 | -$3.12K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | $0.00 derived: sum of 2 quarters · filed 2024-09-30 | $0.00 derived: sum of 3 quarters · filed 2024-09-30 | -$5.51K 10-K · filed 2024-09-30 |
| 2023-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-15 | $0.00 derived: sum of 2 quarters · filed 2024-02-13 | -$5.51K 10-Q · filed 2023-05-15 | $62.51K derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-13 | -$5.51K 10-Q · filed 2024-02-13 | $62.51K derived: sum of 3 quarters · filed 2024-02-13 | $61.95K derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-09-30 | -$5.51K 10-Q · filed 2023-11-14 | $62.51K derived: sum of 2 quarters · filed 2023-11-14 | $61.95K derived: sum of 3 quarters · filed 2023-11-14 | $61.95K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $68.01K derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-29 | $67.46K derived: sum of 2 quarters · filed 2023-09-29 | $67.46K derived: sum of 3 quarters · filed 2023-09-29 | $61.43K 10-K · filed 2023-09-29 |
| 2022-03-31 | -$550.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-15 | -$550.00 derived: sum of 2 quarters · filed 2023-05-15 | -$6.58K 10-Q · filed 2023-05-15 | -$6.58K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-17 | -$6.03K 10-Q · filed 2023-02-17 | -$6.03K derived: sum of 3 quarters · filed 2023-02-17 | -$6.03K derived: sum of 4 quarters · filed 2023-02-17 |
| 2021-09-30 | -$6.03K 10-Q · filed 2022-11-14 | -$6.03K derived: sum of 2 quarters · filed 2022-11-14 | -$6.03K derived: sum of 3 quarters · filed 2022-11-14 | -$5.88K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-23 | $0.00 derived: sum of 2 quarters · filed 2022-09-23 | $154.00 derived: sum of 3 quarters · filed 2022-09-23 | $14.16K 10-K · filed 2022-09-23 |
| 2021-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-13 | $154.00 derived: sum of 2 quarters · filed 2022-05-13 | $14.16K 10-Q · filed 2022-05-13 | |
| 2020-12-31 | $154.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-14 | $14.16K 10-Q · filed 2022-02-14 | ||
| 2020-09-30 | $14.01K 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |